SB

Shivprasad Balasaheb Tarle

Active Director Designated Partner DIN 11354903
DIN 11354903 First appointment Nov 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivprasad Balasaheb Tarle

Data last updated:

Shivprasad Balasaheb Tarle is a Designated Partner at Neurovista Diagnostic Llp (since 2025).

DIN 11354903
Primary Designation Designated Partner
First Appointment 01 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Nov 2025Active

Board colleagues of Shivprasad Balasaheb Tarle

Directorship timeline

Open interactive timeline →
Neurovista Diagnostic Llp
Premium access

Shareholding and investment profile for Shivprasad Balasaheb Tarle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivprasad Balasaheb Tarle

Shivprasad Balasaheb Tarle currently holds 1 directorship: Neurovista Diagnostic Llp (Designated Partner, since 01 Nov 2025).

Shivprasad Balasaheb Tarle was first appointed on 01 Nov 2025 as Designated Partner at Neurovista Diagnostic Llp.

The current boards of Shivprasad Balasaheb Tarle's companies include Anil Chhaburao Jadhav (Neurovista Diagnostic Llp), Chandratej Chandrakant Kadam (Neurovista Diagnostic Llp), Nikhil Vikas Pawar (Neurovista Diagnostic Llp), Rahul Bhimrao Baviskar (Neurovista Diagnostic Llp), Rahul Prakash Modgi (Neurovista Diagnostic Llp), Rahul Sanjay Birla (Neurovista Diagnostic Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available